Category: News

April 1, 2018

BioWave seeks approval for at-home pain-relief device

By Alexander Soule Published 4:17 pm, Friday, March 30, 2018 Even as it sells a pain alleviation device for use in veterans hospitals, a local company is readying a home version that it hopes to sell through pharmacies, doctors and other channels, pending federal approval. BioWave was founded by Norwalk resident Brad Siff to design
March 29, 2018

BioWave’s Smarter Pain Blocking Technology Now Available at 40 VA Medical Centers Nationwide

Proprietary, Non-Opioid Treatment for Pain Captures Over 25% of the VA Hospital Market in One Year March 29, 2018 09:45 AM Eastern Daylight Time NORWALK, Conn.–(BUSINESS WIRE)–BioWave Corp., a Health Technology company that delivers Smarter Pain Blocking Technology™ today announced that its patented technology is now in use at 40 U.S. Department of Veterans Affairs
February 8, 2018

BioWave’s Non-Opioid Smarter Pain Blocking Technology Now Available to All Branches of the United States Military

Awarded Federal Supply Schedule Contract, Building on Official Use by 32 VA Hospitals Nationwide Recommended by Vietnam Veterans of America NORWALK, Conn.–(BUSINESS WIRE)–BioWave Corp., a Health Technology company that delivers Smarter Pain Blocking Technology™ today announced the signing of a Federal Supply Schedule Contract. Building on nearly 100% year-over-year growth in adoption of its patented
February 2, 2018

Norwalk’s BioWave pain-blocking tech expands from sports to veterans

By Kevin Zimmerman – February 2, 2018 If the “no pain, no gain” mantra has become something of a cliché, don’t tell Brad Siff. The founder and president of BioWave, a pain-blocking technology increasingly gaining favor with athletes, physicians and military veterans, had already built a prototype of his device when he tore his anterior
September 25, 2015

BioWave Receives FDA Marketing Clearance for the new BioWaveHOME Neuromodulation Pain Therapy System

We are pleased to announce that BioWave Corporation has received FDA Marketing clearance for its new prescription neuromodulation pain therapy system called BioWaveHOME. BioWaveHOME is indicated for the treatment of acute, chronic or postoperative pain. The company anticipates that BioWaveHOME pain therapy systems will be available for sale starting in November 2015.